Genetic dissection of c-myc apoptotic pathways

Area of Science:

• Oncogene research
• Molecular biology
• Cellular signaling

Background:

• The c-myc oncoprotein is crucial for numerous biological functions.
• Its transactivation domain (TAD) is essential for these activities.
• Understanding TAD's role is key to deciphering c-myc's oncogenic potential.

Purpose of the Study:

• To investigate the distinct functions mediated by different sub-regions of the c-myc transactivation domain (TAD).
• To identify novel c-myc target genes and their roles in cellular processes.
• To explore the relationship between c-myc, interleukin-3 (IL-3) deprivation, chemotherapy, and interferon-gamma (IFN-gamma) signaling.

Main Methods:

• Utilized transactivation domain (TAD) mutants of c-myc to assess specific biological functions.
• Examined apoptosis induction in 32D myeloid cells under IL-3 deprivation and drug treatment.
• Employed cDNA microarrays to identify c-myc-regulated transcripts and analyzed their overlap with IL-3, drug, and IFN-gamma targets.

Main Results:

• Different sub-regions of the c-myc TAD are responsible for distinct functions, including apoptosis promotion and ornithine decarboxylase activation.
• Identified novel c-myc target genes, some of which are modulated by IL-3, cytotoxic drugs, and specific TAD sub-regions.
• Demonstrated that c-myc-overexpressing cells exhibit increased sensitivity to IFN-gamma-mediated apoptosis, linked to shared target genes.

Conclusions:

• The biological functions of c-myc are separable and can be attributed to specific regions within its transactivation domain (TAD).
• A novel set of c-myc target genes has been identified, contributing to its diverse cellular roles.
• These findings reveal a functional link between c-myc, its target genes, and the apoptotic pathways induced by IFN-gamma.